It depends on your medication, your body, your tolerance, the product, and what your healthcare provider says is safe for you
If you are not seeing expected results, review the comprehensive guide on why weight loss might stall before adjusting your approach
In the diabetes group, patients on semaglutide had a fourfold increased risk of NAION compared to those on other treatments
FDA specifically approves Wegovy for obesity management, while Ozempic and Rybelsus are primarily diabetes medications that doctors prescribe off-label for weight loss
That means they havent gone through the same testing for safety, effectiveness, or quality
This introductory offer is good for the first two months of therapy and applies to the two lowest doses (0.25 mg and 0.5 mg) of Wegovy or Ozempic